Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

4 Résultats
authFullName_s : Lotfi Benboubker

Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial

Philippe Moreau , Cyrille Hulin , Aurore Perrot , Bertrand Arnulf , Karim Belhadj , et al.
Lancet Oncology, 2021, 22 (10), pp.1378-1390. ⟨10.1016/S1470-2045(21)00428-9⟩
Article dans une revue hal-03604926v1
Image document

Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma

Anais Schavgoulidze , Valérie Lauwers-Cances , Aurore Perrot , Titouan Cazaubiel , Marie-Lorraine Chretien , et al.
Haematologica, 2023, 108 (5), pp.1374. ⟨10.3324/haematol.2021.280566⟩
Article dans une revue hal-03801805v1

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Philippe Moreau , Michel Attal , Cyrille Hulin , Bertrand Arnulf , Karim Belhadj , et al.
The Lancet, 2019, 394 (10192), pp.29-38. ⟨10.1016/S0140-6736(19)31240-1⟩
Article dans une revue hal-03605015v1

Long Term Follow-up of Hematopoietic Stem Cell Transplantation (HSCT) for Primary Plasma Cell Leukemia (pPCL): Final Results of a Prospective Study of IFM Group

Bruno Royer , Momar Diouf , Murielle Roussel , Lionel Karlin , Cyrille Hulin , et al.
Article dans une revue hal-03605055v1